Compare ENLIE Pharmaceutical JSC with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
17.0%
0%
17.0%
6 Months
-2.5%
0%
-2.5%
1 Year
4.46%
0%
4.46%
2 Years
21.88%
0%
21.88%
3 Years
17.0%
0%
17.0%
4 Years
5.41%
0%
5.41%
5 Years
0%
0%
0.0%
ENLIE Pharmaceutical JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-26.15
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0.94
Sales to Capital Employed (avg)
12,069.16
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.28%
ROE (avg)
6.35%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-9.33
EV to EBITDA
-91.59
EV to Capital Employed
0.49
EV to Sales
0.58
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.20%
ROE (Latest)
-8.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
143,050.00
118,986.00
20.22%
Operating Profit (PBDIT) excl Other Income
161.50
5,059.10
-96.81%
Interest
3,846.90
3,086.70
24.63%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5,674.60
-1,440.90
-293.82%
Operating Profit Margin (Excl OI)
-26.70%
15.10%
-4.18%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 20.22% vs 57.58% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -293.82% vs 66.51% in Dec 2022
About ENLIE Pharmaceutical JSC 
ENLIE Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Enlie Pharmaceutical Joint Stock Company, formerly Becamex Pharmaceutical Joint Stock Company, is a Vietnam-based company operating in the pharmaceutical industry. The Company is mainly engaged in the production and commerce of pharmaceutical preparations, as well as medical equipment and health supplements. Besides, it has expanded its business into the real estate industry, with the development of various commercial and residential infrastructures for lease.






